Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Re Agreement

13 Aug 2007 07:00

Embargoed Release: 07:00hrs Monday 13 August 2007

SOPHEON PLC ("Sopheon") SOPHEON NAMED TO ENABLE TRANSITION OF IDe CUSTOMERS Arrangement Extends Sopheon's Position as Industry's Leading Provider of Product Roadmapping, Planning and Process Automation Solutions

Sopheon plc announces today that its affiliate, Sopheon Corporation, has entered into an agreement with Integrated Development Enterprise, Inc. ("IDe") under which Sopheon intends to offer transition services and support to IDe customers previously covered by IDe maintenance and support contracts. The agreement follows a recent decision by IDe to discontinue its business.

Founded in 1998, Boston-based IDe specialized in providing product portfolio management software solutions to large manufacturers and services companies. IDe has announced Sopheon, a former competitor, to its customers as an alternate source of services and assistance that IDe will no longer be able to provide.

Terms of the agreement afford Sopheon exclusive access to such IDe assets as its customer list, software code and all documentation relating to IDe's software. Sopheon intends to contact each of IDe's customers to discuss potential support options, including transitioning to Sopheon's Accolade‚® software and services. However, Sopheon is not committed to assume, nor is it legally bound to, any of IDe's obligations to IDe's former end-users, and terms and conditions of the transition will be as agreed between Sopheon and IDe's individual customers. IDe's client base of 18 companies is approximately one-fifth the size of Sopheon's and similarly includes many Fortune 1000 companies.

Sopheon's outreach to IDe customers began last week. Sopheon said that it views the initiative as a unique opportunity to expand its customer population while also increasing maintenance and support revenue.

Less than 60 days ago, Sopheon was successful in a bid to acquire the assets of Alignent Software, a California-based supplier of advanced product and technology roadmapping solutions. The consolidation of Alignent enabled Sopheon to extend its product life cycle management solution footprint to include product planning. Sopheon believes that the agreement with IDe will build on Sopheon's history of steady, substantial growth in the expanding product portfolio and innovation process management market. Since Sopheon's launch of its Accolade solution six years ago, its Accolade-related revenues in dollar terms have increased at an average rate of nearly 50% per year.

Barry Mence, chairman of Sopheon, commented:

"There is good compatibility between IDe's flagship offering and Sopheon's Accolade. There is also a strong fit between our client bases. Add to this the fact that we already know a fair amount about IDe's application, and we believe we are in a position to offer a seamless transition to IDe customers."

For further information contact:

Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO David Newton Seymour Pierce Limited Tel: +44 (0) 207 107 8000 Jonathan Wright, Nominated Advisers Andrew Tan Hansard Group Tel : + 44 (0) 207 245 1100 + 44 (0) 7957 203 685 Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010 About Sopheon

Sopheon is an international provider of software and services that help organizations improve the business impact of product innovation. Sopheon's Accolade system automates and governs the innovation process, enabling companies to increase revenue and profits from new products. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Euronext in the Netherlands. For more information, please visit www.sopheon.com.

SOPHEON PLC
Date   Source Headline
11th Apr 20167:00 amRNSDirectors Options and Shareholding
21st Mar 20167:00 amRNSAmendment to Terms of Convertible Loan Stock
17th Mar 20167:00 amRNSFinal Results
21st Jan 20168:29 amRNSAccolade Release 10.2
8th Jan 20167:00 amRNSTrading Update and Board Change
20th Oct 20159:33 amRNSDirector Dealing
19th Oct 20157:00 amRNSDirector Dealing
9th Oct 20153:41 pmRNSDirector Dealing
9th Oct 20151:12 pmRNSDirector Dealing
2nd Oct 20153:39 pmRNSDirector Dealing
23rd Sep 20157:00 amRNSAccolade Release 10.1
27th Aug 20157:01 amRNSHalf Yearly Report
1st Jul 20157:00 amRNSDirector Shareholding
10th Jun 20151:44 pmRNSResult of AGM
10th Jun 20157:00 amRNSAGM Statement
2nd Jun 20157:00 amRNSAccolade 10.0 release
15th May 20153:10 pmRNSNotice of AGM
7th May 201511:40 amRNSDIRECTOR SHAREHOLDING
23rd Apr 201511:10 amRNSDirector Shareholding
20th Apr 201511:43 amRNSDirector Shareholding
13th Apr 20152:03 pmRNSHolding(s) in Company
10th Apr 201511:05 amRNSHolding(s) in Company
8th Apr 20157:00 amRNSDELISTING FROM ALTERNEXT AMSTERDAM
19th Mar 20157:00 amRNSFinal Results
20th Feb 20157:00 amRNSSopheon Releases Accolade® 9.3
5th Feb 20154:12 pmRNSChange of Registered Office
28th Jan 20157:00 amRNSTrading Update
19th Dec 201410:30 amRNSResult of General Meeting
12th Dec 20143:00 pmRNSTrading Update
2nd Dec 20144:00 pmRNSProposed Share Subdivision
2nd Dec 20147:00 amRNSDirector/PDMR Shareholding
27th Oct 20144:15 pmRNSDirector/PDMR Shareholding
22nd Oct 20143:45 pmRNSDirector/PDMR Shareholding
21st Oct 20147:00 amRNSDirector/PDMR Shareholding
17th Oct 20141:50 pmRNSDirector/PDMR Shareholding
10th Oct 201411:15 amRNSResult of GM and Further re Share Consolidation
24th Sep 20147:00 amRNSAccolade 9.2 Release
12th Sep 20147:00 amRNSShare Consolidation
28th Aug 20147:00 amRNSHalf Yearly Report
11th Jun 201412:20 pmRNSResult of AGM
11th Jun 20147:00 amRNSAGM Statement
2nd Jun 20147:00 amRNSAmendment To The Terms Of Convertible Loan Stock
22nd May 20147:00 amRNSAlternext Amsterdam
1st May 20147:00 amRNSInterim Management Statement
22nd Apr 20147:01 amRNSSopheon Delivers Accolade Release 9.1
11th Apr 20147:00 amRNSWind Down Of Alternext Amsterdam
20th Mar 20147:01 amRNSTotal Voting Rights
20th Mar 20147:00 amRNSPreliminary Results
6th Mar 20147:00 amRNSNew Debt Facility
29th Jan 20148:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.